help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Greenman, Y.
Right arrow Articles by Melmed, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Greenman, Y.
Right arrow Articles by Melmed, S.

Journal of Clinical Endocrinology & Metabolism, Vol 81, 1628-1633, Copyright © 1996 by Endocrine Society

ARTICLES

Remission of acromegaly caused by pituitary carcinoma after surgical excision of growth hormone-secreting metastasis detected by 111-indium pentetreotide scan

Y Greenman, P Woolf, J Coniglio, R O'Mara, L Pei, JW Said and S Melmed
Department of Medicine, Cedars Sinai Research Institute-University of California School of Medicine, Los Angeles, 90048, USA.

GH-secreting carcinomas of the pituitary are extremely rare. We describe a 37-yr-old woman with refractory acromegaly 15 yr after transphenoidal surgery and radiotherapy, with no evidence of a recurrent pituitary mass. Scanning with 111-indium pentetreotide revealed an area of intense activity in the left neck. A 3.5 x 2.5-cm mass was excised from the neck after demonstrating an arterio-venous GH gradient of 7:1. GH levels (50 ng/mL) dropped to 0.8 ng/mL 3 h after surgery and remained normal. GH gene expression was demonstrated in the metastasis by Northern and Western blot analyses and by positive immunocytochemistry and immunoelectron microscopy. In vitro cultured cells responded to GHRH and TRH by increasing GH levels (P < 0.01). Medium GH was identical to authentic pituitary GH, as demonstrated by high pressure liquid chromatography. RT-PCR of hypothalamic hormone receptor messenger RNA in the mass revealed somatostatin receptor subtypes 2, 3, and 5 and GHRH, TRH, and dopamine receptor expression. No GH gene amplification, rearrangement, or gsp mutation was found. RB gene deletion and H-ras mutations, previously reported in PRL- and ACTH- secreting carcinomas, were not detected. In conclusion, clinical and molecular features of a GH-secreting pituitary carcinoma are presented. This metastatic lesion synthesized GH and expressed functional hypothalamic hormone receptors.


This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
G. A. Kaltsas, P. Nomikos, G. Kontogeorgos, M. Buchfelder, and A. B. Grossman
Diagnosis and Management of Pituitary Carcinomas
J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 3089 - 3099.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
C. W. le Roux, A. Mulla, and K. Meeran
Pituitary Carcinoma as a Cause of Acromegaly
N. Engl. J. Med., November 29, 2001; 345(22): 1645 - 1646.
[Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
P. Petrossians, W. De Herder, D. Kwekkeboom, G. Lamberigts, A. Stevenaert, and A. Beckers
Malignant Prolactinoma Discovered by D2 Receptor Imaging
J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 398 - 401.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1996 by The Endocrine Society